Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing

Journal of the American Academy of Dermatology

Volumn 52, Issue 1, 2005, Pages 140-141

  Feldman, Steven R ^c   Nijsten, Tamar ^a   Margolis, David J ^b   Rolstad, Tara ^d  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d Portland   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; ETRETIN; METHOTREXATE; PSORALEN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG UTILIZATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PATIENT; PATIENT SATISFACTION; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; PSORIASIS; PUVA; SELF REPORT; SYSTEMIC THERAPY; TREATMENT OUTCOME;

ACITRETIN; CYCLOSPORINE; FEMALE; FICUSIN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATOLYTIC AGENTS; MALE; METHOTREXATE; MIDDLE AGED; PATIENT SATISFACTION; PHOTOSENSITIZING AGENTS; PSORIASIS; PUVA THERAPY; TREATMENT OUTCOME;

EID: 11144258883     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.08.045     Document Type: Article

References (4)

1. R.S. Stern, T. Nijsten, S.R. Feldman, D.J. Margolis, J. Thomas, and T. Rolstad Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction J Invest Dermatol Symp Proc 9 2004 136 139
2. Nijsten T, Margolis DJ, Feldman SR, Rolstad T, Stern RS. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. J Am Acad Dermatol (in press).
3. G. Krueger, J. Koo, M. Lebwohl, A. Menter, R.S. Stern, and T. Rolstad The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey Arch Dermatol 137 2001 280 284
4. C.S. Carlin, S.R. Feldman, J.G. Krueger, A. Menter, and G.G. Krueger A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis J Am Acad Dermatol 50 2004 859 866